Patients taking Kerendia saw significant reduction in cardiovascular death and hospitalization and urgent visits for heart ...

Following priority review, the U.S. Food and Drug Administration approved Bayer's Kerendia (finerenone) for the treatment of ...

The FDA expanded the indication for finerenone (Kerendia) in heart failure (HF), drug manufacturer Bayer announced.

Heart failure, a condition where the heart doesn't pump blood efficiently, manifests through symptoms like shortness of ...

US FDA approves Bayer’s finerenone for new indication in patients with heart failure with left ventricular ejection fraction of ≥ 40%: Berlin Wednesday, July 16, 2025, 13:00 H ...

Heart failure, a leading cause of death in the US, can be triggered by cardiac amyloidosis, a condition often misdiagnosed as ...

Heart disease is killing more women in Pakistan than previously understood, with female patients experiencing higher mortality rates, more severe symptoms and delayed diagnoses compared to men, ...

Wearables and telehealth are teaming up to transform chronic care. This connected model offers real-time data for proactive, ...

Micah Clayborne was diagnosed with Danon disease, a rare condition, after complaining of chest pains. He needed a heart ...

The use of SGLT2 inhibitors has been a game-changer in the treatment of heart failure (HF). Now, another drug class has ...

The US regulator has cleared use of Kerendia (finerenone) for the treatment of heart failure patients who have a left ...

Piedmont has expanded access to outpatient heart failure management with a new heart failure clinic at Piedmont Newton ...